You are here

funding

Fresh Biopharmas Join the Race to Cutting-Edge Treatments and Testing

Fresh Biopharmas Join the Race to Cutting-Edge Treatments and Testing

BioSpace

Tectonic Therapeutics

Alchemab Therapeutics

Flag link:

Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar

Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar

BioPharma Dive

Jaguar Gene Therapy

Arch Venture Partners

Flag link:

Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trial

Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trial

Pharmaforum

Flag link:

ValenzaBio Closes Series A Financing Round Worth $70 Million

ValenzaBio Closes Series A Financing Round Worth $70 Million

BioSpace

Flag link:

Ventus raises $100M to pursue NLRP3, crack undruggable targets

Ventus raises $100M to pursue NLRP3, crack undruggable targets

Fierce Biotech

Ventus Therapeutics

clinical trials

undruggable targets

Flag link:

With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers

With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers

MedCity News

Volastra Therapeutics

cancer metastasis

Flag link:

Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push

Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push

Fierce Biotech

venture capital

Flag link:

Alloy Therapeutics nabs a $75M series C to sow more seeds into the biotech ecosystem

Alloy Therapeutics nabs a $75M series C to sow more seeds into the biotech ecosystem

Fierce Biotech

Alloy Therapeutics

drug development

Flag link:

After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B

After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B

Fierce Biotech

venture capital

antibody-drug conjugate

Flag link:

3B Future Health launches 2nd fund for U.S., European early-stage biotechs

3B Future Health launches 2nd fund for U.S., European early-stage biotechs

Fierce Biotech

venture capital

3B Future Health Ventures

Flag link:

Record funding flowed into cell, gene therapy companies last year

Record funding flowed into cell, gene therapy companies last year

BioPharma Dive

Flag link:

Three Biotechs Obtain Millions in New Financing Rounds Announced Monday

Three Biotechs Obtain Millions in New Financing Rounds Announced Monday

BioSpace

Flag link:

Ventyx bags $114M to test drugs against hot immunology targets

Ventyx bags $114M to test drugs against hot immunology targets

Fierce Biotech

Ventyx Biosciences

Flag link:

FogPharma comes through the clearing with a meaty $107M raise for 'undruggable' targets

FogPharma comes through the clearing with a meaty $107M raise for 'undruggable' targets

Fierce Biotech

undruggable targets

Flag link:

Xilio raises $95M to take twists on Yervoy and IL-2 into clinic

Xilio raises $95M to take twists on Yervoy and IL-2 into clinic

Fierce Biotech

Xilio Therapeutics

clinical trials

Flag link:

The reckoning begins for biotech-focused SPACs

The reckoning begins for biotech-focused SPACs

EP Vantage

Flag link:

Advent raises $215M to nurture another troop of biotechs

Advent raises $215M to nurture another troop of biotechs

Fierce Biotech

Advent Life Sciences

venture capital

Flag link:

House committee proposes $500M in COVID funding for FDA

House committee proposes $500M in COVID funding for FDA

RAPS.org

Flag link:

Drug Farm bags $56M to take novel hepatitis B drug into humans

Drug Farm bags $56M to take novel hepatitis B drug into humans

Fierce Biotech

drug development

Flag link:

How will the Biden administration affect funding for life science research?

How will the Biden administration affect funding for life science research?

Endpoints

Flag link:

Pages